| Bradley Pharmaceuticals 2007 Third Quarter Results
FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, (Nachrichten) Inc. announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Third Quarter of 2007 -- Launched ADOXA(R) 150mg capsules. -- Paid outstanding principal balance of $62.4 million under old credit facility on August 3, 2007 with existing cash and cash equivalents, concurrently with entering into a new credit facility and wrote-off deferred financing costs of $3.3 million related to old facility. -- On October 29, 2007, the Company entered into a definitive merger agreement with Nycomed US Inc. Bradley reported that net sales for the quarter ended September 30, 2007 were approximately $33.6 million, a decrease of $1.6 million, or 5%, from net sales of $35.2 million for the quarter ended September 30, 2006.
Questions raised about drug being studied for MS
A group of American scientists has warned other researchers that an acne drug being tested as a possible treatment for a variety of neurodegenerative diseases - including in Canada for multiple sclerosis - may actually cause harm. The scientists reported that in a clinical trial of patients with amyotrophic lateral sclerosis or Lou Gehrig's disease, those who received the drug minocycline declined more rapidly than those who received a placebo. Their report, published Thursday in the journal Lancet Neurology, comes just a week after the Multiple Sclerosis Society of Canada announced it was funding a multi-centre Phase 3 trial to look at whether the inexpensive and off-patent minocycline can slow the progression of MS when treatment is commenced in the earliest stages of the disease.
Intermission: Point and click tricks
Digital cameras revolutionized the way that we photograph the world. Where once we might have asked a stranger to take a photo of us, we now extend our arms and direct the lens at our face before opening the shutter. Once we hear the synthetic “click" of a closed shutter, we flip the camera around to view the photograph on the LCD screen to decide if another take is necessary. It's the digital self-portrait, and it is unavoidable on Facebook. It has become such a symbol for the way we share ourselves with the virtual world that it has been absorbed by marketers as a means of conveying modernity (for proof of this, look no further than the poster for “Marie Antoinette"). .
Feeling stressed? Your skin and hair can show it
Feeling stressed? Your skin, hair and nails can show it as they're the external indicators. While everyone knows that stress can take a toll on a person physically and psychologically, researchers in the United States have carried out a study and found that it also can lead to dermatological problems, like acne, brittle nails or even hair loss, the ScienceDaily reported. "When a person becomes stressed, the level of the body's stress hormone (cortisol) rises. This in turn causes an increase in oil production, which can lead to oily skin, acne and other related skin problems. "Stress can aggravate the skin and trigger unexpected flare-ups that, in effect, create more stress for patients," lead researcher Dr Flor A. Mayoral of the University of Miami's Miller School of Medicine was quoted as saying.
Chris Gibson, Author of the Book, "Acne Free in 3 Days," Believes Antibiotics are a Problematic Treatment Choice for ...
Health experts say overuse of antibiotics has contributed to the rapid spread of MRSA. The public health concern of growing antimicrobial resistance is a prime reason 50% of dermatologists report cutting back on antibiotics to treat acne according to the Galderma Quality Report for Dermatology and Managed Care. Chris Gibson, a holistic health and lifestyle coach and author of the book, "Acne Free in 3 Days," believes antibiotics are a problematic treatment choice for acne. He urges parents to be cautious when seeking an acne regimen that's safe and effective for kids. .
|
